For: | Zheng L, Ji YY, Wen XL, Duan SL. Fecal microbiota transplantation in the metabolic diseases: Current status and perspectives. World J Gastroenterol 2022; 28(23): 2546-2560 [PMID: 35949351 DOI: 10.3748/wjg.v28.i23.2546] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v28/i23/2546.htm |
Number | Citing Articles |
1 |
Xiao-Xia Qiu, Sheng-Li Cheng, Yan-Hui Liu, Yu Li, Rui Zhang, Nan-Nan Li, Zheng Li. Fecal microbiota transplantation for treatment of non-alcoholic fatty liver disease: Mechanism, clinical evidence, and prospect. World Journal of Gastroenterology 2024; 30(8): 833-842 doi: 10.3748/wjg.v30.i8.833
Abstract(223) |
Core Tip(237) |
Full Article(HTML)(1871)
|
Full Article with Cover (PDF)-3407K(41)
|
Full Article (Word)-1043K(11)
|
Audio-739K(1)
|
Peer-Review Report-244K(29)
|
Answering Reviewers-66K(27)
|
Full Article (PDF)-3043K(101)
|
Full Article (XML)-141K(30)
|
Times Cited (1)
|
Total Visits (3485)
|
Open
|
2 |
Carlo Airola, Andrea Severino, Serena Porcari, William Fusco, Benjamin H. Mullish, Antonio Gasbarrini, Giovanni Cammarota, Francesca Romana Ponziani, Gianluca Ianiro. Future Modulation of Gut Microbiota: From Eubiotics to FMT, Engineered Bacteria, and Phage Therapy. Antibiotics 2023; 12(5): 868 doi: 10.3390/antibiotics12050868
|
3 |
Muthukumaran Jayachandran, Shen Qu. Non-alcoholic fatty liver disease and gut microbial dysbiosis- underlying mechanisms and gut microbiota mediated treatment strategies. Reviews in Endocrine and Metabolic Disorders 2023; 24(6): 1189 doi: 10.1007/s11154-023-09843-z
|
4 |
Hao Zhang, Li Fu, Xinwen Leiliang, Chunrun Qu, Wantao Wu, Rong Wen, Ning Huang, Qiuguang He, Quan Cheng, Guodong Liu, Yuan Cheng. Beyond the Gut: The intratumoral microbiome's influence on tumorigenesis and treatment response. Cancer Communications 2024; doi: 10.1002/cac2.12597
|
5 |
Lie Zheng, Sheng-Lei Duan, Yan-Cheng Dai, Shi-Cheng Wu. Role of adherent invasive <i>Escherichia coli</i> in pathogenesis of inflammatory bowel disease. World Journal of Clinical Cases 2022; 10(32): 11671-11689 doi: 10.12998/wjcc.v10.i32.11671
|
6 |
Xiaomin Liu, Mei Liu, Ming Zhao, Ping Li, Changxing Gao, Xinyu Fan, Guangyan cai, Qianjin Lu, Xiangmei Chen. Fecal microbiota transplantation for the management of autoimmune diseases: Potential mechanisms and challenges. Journal of Autoimmunity 2023; 141: 103109 doi: 10.1016/j.jaut.2023.103109
|
7 |
Xiaofeng Liu, Shuzhen Yu, Yao Zhang, Wei Zhang, Hao Zhong, Xiaoqin Lu, Rongfa Guan. A review on the protective effect of active components in Antrodia camphorata against alcoholic liver injury. Journal of Ethnopharmacology 2023; 300: 115740 doi: 10.1016/j.jep.2022.115740
|
8 |
Azin Pakmehr, Seyed Mohammad Mousavi, Hanieh-Sadat Ejtahed, Zahra Hoseini-Tavassol, Seyed Davar Siadat, Shirin Hasani-Ranjbar, Bagher Larijani. The Effect of Fecal Microbiota Transplantation on Cardiometabolic Risk Factors: A Systematic Review and Meta-Analysis. Clinical Therapeutics 2023; doi: 10.1016/j.clinthera.2023.11.015
|
9 |
Qi-Ming Zhou, Lie Zheng. Research progress on the relationship between Paneth cells-susceptibility genes, intestinal microecology and inflammatory bowel disease. World Journal of Clinical Cases 2023; 11(34): 8111-8125 doi: 10.12998/wjcc.v11.i34.8111
Abstract(286) |
Core Tip(219) |
Full Article(HTML)(1146)
|
Full Article with Cover (PDF)-1891K(43)
|
Full Article (Word)-752K(13)
|
Audio-1485K(4)
|
Peer-Review Report-261K(31)
|
Answering Reviewers-270K(24)
|
Full Article (PDF)-1676K(60)
|
Full Article (XML)-317K(20)
|
Times Cited (0)
|
Total Visits (2396)
|
Open
|
10 |
Eva Zikou, Chrysi Koliaki, Konstantinos Makrilakis. The Role of Fecal Microbiota Transplantation (FMT) in the Management of Metabolic Diseases in Humans: A Narrative Review. Biomedicines 2024; 12(8): 1871 doi: 10.3390/biomedicines12081871
|
11 |
Meenakshi Kaira, Vaibhav Walia, Munish Garg. Effect of l-carnitine alone and in combination with metformin on the behavioral and biochemical alterations induced by streptozotocin in Wistar rats. Nutrire 2024; 49(1) doi: 10.1186/s41110-024-00268-5
|
12 |
Connie A. Rojas, Zhandra Entrolezo, Jessica K. Jarett, Guillaume Jospin, Dawn D. Kingsbury, Alex Martin, Jonathan A. Eisen, Holly H. Ganz. Microbiome Responses to Fecal Microbiota Transplantation in Cats with Chronic Digestive Issues. Veterinary Sciences 2023; 10(9): 561 doi: 10.3390/vetsci10090561
|
13 |
Lin Yuan, Ying Li, Moutong Chen, Liang Xue, Juan Wang, Yu Ding, Qihui Gu, Jumei Zhang, Hui Zhao, Xinqiang Xie, Qingping Wu. Therapeutic applications of gut microbes in cardiometabolic diseases: current state and perspectives. Applied Microbiology and Biotechnology 2024; 108(1) doi: 10.1007/s00253-024-13007-7
|
14 |
Lie Zheng. New insights into the interplay between intestinal flora and bile acids in inflammatory bowel disease. World Journal of Clinical Cases 2022; 10(30): 10823-10839 doi: 10.12998/wjcc.v10.i30.10823
|
15 |
En Tian, Feng Wang, Lei Zhao, Yan Sun, Jurong Yang. The pathogenic role of intestinal flora metabolites in diabetic nephropathy. Frontiers in Physiology 2023; 14 doi: 10.3389/fphys.2023.1231621
|
16 |
Xiaxin Zhu, Chi Zhang, Shuyan Feng, Ruonan He, Shuo Zhang. Intestinal microbiota regulates the gut-thyroid axis: the new dawn of improving Hashimoto thyroiditis. Clinical and Experimental Medicine 2024; 24(1) doi: 10.1007/s10238-024-01304-4
|
17 |
Juan Zhang, Honggang Wang, Ying Liu, Min Shi, Minna Zhang, Hong Zhang, Juan Chen. Advances in fecal microbiota transplantation for the treatment of diabetes mellitus. Frontiers in Cellular and Infection Microbiology 2024; 14 doi: 10.3389/fcimb.2024.1370999
|
18 |
|
19 |
Zhi Qiang Luo, Ya Jing Huang, Ze Hua Chen, Chen Yin Lu, Biao Zhou, Xiang Hao Gong, Zhen Shen, Tao Wang. A decade of insight: bibliometric analysis of gut microbiota’s role in osteoporosis (2014–2024). Frontiers in Medicine 2024; 11 doi: 10.3389/fmed.2024.1409534
|
20 |
Aleš Franc, David Vetchý, Nicole Fülöpová. Commercially Available Enteric Empty Hard Capsules, Production Technology and Application. Pharmaceuticals 2022; 15(11): 1398 doi: 10.3390/ph15111398
|